AI Robotics in Medicine
PublicTracking updates in AI Robotics in the healthcare industry
Unfold AI maps prostate cancer across entire care pathway
Tuesday, Jul 28, 2026
Avenda Health's FDA-cleared Unfold AI platform now covers the full prostate cancer care continuum, from active surveillance to radiotherapy, uniting MRI, pathology, and biomarkers into personalized 3D maps.
A 2024 study found it improves prediction of focal therapy success by 77% and shifts treatment recommendations toward less invasive options in one of three cases.
The deployment at major academic centers and community practices signals a concrete move toward AI-guided, individualized treatment planning.
Tracking: Medicine Robotics · AI Medicine · AI Healthcare
1. Avenda Health's Unfold AI deployed across entire prostate cancer care pathway
Avenda Health announced on July 28, 2026, that its FDA-cleared Unfold AI platform is now in use across the full prostate cancer care continuum, including active surveillance, focal therapy, surgery, and radiotherapy.
The software combines MRI, pathology, biomarkers, and clinical data to generate personalized 3D cancer maps that guide treatment planning.
Unfold AI is already adopted at major academic centers such as UCLA, the University of Alabama at Birmingham, and the University of Michigan Health, as well as community practices in multiple states.
A 2024 Journal of Urology study found the platform improves physicians' ability to predict focal therapy success by 77%. The tool has also shifted treatment recommendations toward less invasive options in one of three cases.
Key facts:
- Unfold AI is FDA-cleared and used across active surveillance, focal therapy, surgery, and radiotherapy.
- The platform improved prediction of focal therapy success by 77% (2024 Journal of Urology study).
- Unfold AI shifted physicians' treatment recommendations toward minimally invasive options in one in three cases.
- Adopted at UCLA, University of Alabama at Birmingham, University of Michigan Health, and community practices.
- Announced July 28, 2026, by Avenda Health based in Culver City, California.
Why it matters: Unfold AI gives physicians a data-driven, 3D understanding of each patient's cancer, enabling more precise and less invasive treatments. This could reduce overtreatment, lower healthcare costs, and improve quality of life for prostate cancer patients.
The platform's growing adoption at both academic and community practices signals a shift toward AI-guided, personalized oncology care. Watch for further integration into robotic surgery and real-time intraoperative guidance.